{
    "paper_id": "ffbe3aa5c899b008976c5b42f91d022ea001b34a",
    "metadata": {
        "title": "Journal Pre-proofs Bioactive compounds with possible inhibitory activity of Angiotensin-Con- verting Enzyme-II; a gate to manage and prevent COVID-19 Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme- II; a gate to manage and prevent COVID-19",
        "authors": [
            {
                "first": "Farid",
                "middle": [],
                "last": "Dabaghian",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Mahnaz",
                "middle": [],
                "last": "Khanavi",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Tehran University of Medical Sciences",
                    "location": {
                        "settlement": "Tehran",
                        "country": "Iran"
                    }
                },
                "email": ""
            },
            {
                "first": "Mohammad",
                "middle": [
                    "M"
                ],
                "last": "Zarshenas",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "Tehran University of Medical Sciences",
                    "location": {
                        "settlement": "Tehran",
                        "country": "Iran"
                    }
                },
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Till now, no treatment or vaccine has been characterized for COVID-19 (1) . Angiotensin-Converting Enzyme-II (ACE-II) receptor, most likely the COVID-19 target, plays essential roles in virus transmission to the alveolar cells (2) . Accordingly, agents with potential inhibition or regulation of ACE-II receptors might be effective in COVID-19 management (3) . ",
            "cite_spans": [
                {
                    "start": 70,
                    "end": 73,
                    "text": "(1)",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 227,
                    "end": 230,
                    "text": "(2)",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 355,
                    "end": 358,
                    "text": "(3)",
                    "ref_id": "BIBREF3"
                }
            ],
            "ref_spans": [],
            "section": "Letter to editors"
        },
        {
            "text": "The averting impact of Naringin on pro-inhibitory cytokines (increased in COVID-19 infection)",
            "cite_spans": [],
            "ref_spans": [],
            "section": "8-trihydroxyanthraquinone) are of most considerable natural ACE-II inhibitors (4-6)."
        },
        {
            "text": "including Cyclooxygenase-II, Interleukin-6 and -1\u03b2, and Nitric oxide synthase is considerable (5) .",
            "cite_spans": [
                {
                    "start": 94,
                    "end": 97,
                    "text": "(5)",
                    "ref_id": "BIBREF5"
                }
            ],
            "ref_spans": [],
            "section": "8-trihydroxyanthraquinone) are of most considerable natural ACE-II inhibitors (4-6)."
        },
        {
            "text": "Glycyrrhizin can inhibit COVID-19 S-protein binding to ACE-II receptors (7) . Emodin, a bioactive antiviral agent may prevent S-protein binding to ACE-II receptors. Thus, Emodin and probably Aloe-emodin can stave off the COVID-19 infection via competing with S-protein in binding to ACE-II (7) . Rheum palmatum L. and Aloe vera (L.) Burm.f. are rich sources of these compounds (8) .",
            "cite_spans": [
                {
                    "start": 72,
                    "end": 75,
                    "text": "(7)",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 290,
                    "end": 293,
                    "text": "(7)",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 377,
                    "end": 380,
                    "text": "(8)",
                    "ref_id": "BIBREF8"
                }
            ],
            "ref_spans": [],
            "section": "8-trihydroxyanthraquinone) are of most considerable natural ACE-II inhibitors (4-6)."
        },
        {
            "text": "Based on this opinion (Figure 1) , concerned compounds could be applied in prevention and management of COVID-19 solely or combination with conventional interventions. ",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 22,
                    "end": 32,
                    "text": "(Figure 1)",
                    "ref_id": "FIGREF1"
                }
            ],
            "section": "8-trihydroxyanthraquinone) are of most considerable natural ACE-II inhibitors (4-6)."
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Purposing Saikosaponins for the treatment of COVID-19",
            "authors": [
                {
                    "first": "E",
                    "middle": [
                        "I"
                    ],
                    "last": "Bahbah",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Negida",
                    "suffix": ""
                },
                {
                    "first": "Msjmh",
                    "middle": [],
                    "last": "Nabet",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Med Hypotheses",
            "volume": "140",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "COVID-19 and the cardiovascular system",
            "authors": [
                {
                    "first": "Y-Y",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "Y-T",
                    "middle": [],
                    "last": "Ma",
                    "suffix": ""
                },
                {
                    "first": "J-Y",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Xjnrc",
                    "middle": [],
                    "last": "Xie",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Angiotensin converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Gheblawi",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Viveiros",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Circ Res",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Potential natural compounds for preventing 2019-nCoV infection",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "Qjp",
                    "middle": [],
                    "last": "Du",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Citrus fruits are rich in flavonoids for immunoregulation and potential targeting ACE2",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction",
            "authors": [
                {
                    "first": "T-Y",
                    "middle": [],
                    "last": "Ho",
                    "suffix": ""
                },
                {
                    "first": "S-L",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "J-C",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "C-C",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "C-Yjar",
                    "middle": [],
                    "last": "Hsiang",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Antiviral Res",
            "volume": "74",
            "issn": "2",
            "pages": "92--101",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Discovery of Anti-2019-nCoV Agents from Chinese Patent Drugs via Docking Screening",
            "authors": [
                {
                    "first": "Y-M",
                    "middle": [],
                    "last": "Yan",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Shen",
                    "suffix": ""
                },
                {
                    "first": "Y-K",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "J-J",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Y-X",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "Anti-SARS coronavirus 3C-like protease effects of Rheum palmatum L. extracts",
            "authors": [
                {
                    "first": "W",
                    "middle": [],
                    "last": "Luo",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Su",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Gong",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Biosci Trends",
            "volume": "3",
            "issn": "4",
            "pages": "124--126",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "Bioactive compounds are valuable for drug development and adjuvant therapy of such infection. These compounds can act either as preventive agents or treatment accelerators. Naringin (a flavanone-7-O-glycoside with potential inhibition of COVID-19 binding to ACE-II receptors), Naringenin and Hesperetin (flavanone), Hesperidin (flavanone glycoside), Baicalin and Neohesperidin (flavone glycoside), Nobiletin (O-methylated flavone), Scutellarin (a flavone), Nicotinamine (nonproteinogenic amino acid), Glycyrrhizin (saponin) and Emodin (6-methyl-1,3,",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Schematic view of bioactive compounds with ACE-II inhibitory activities",
            "latex": null,
            "type": "figure"
        }
    },
    "back_matter": [
        {
            "text": "The authors of this manuscript have no conflict of interest.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conflict of interest"
        }
    ]
}